Abstract:Background and Aims: Metastasis is the major cause of death in patients with colorectal carcinoma (CRC).Thyroid hormone receptor interacting protein 6 (TRIP6) is an adaptor protein that regulates cell motility and anti-apoptotic signaling.This study aimed to elucidate the biological function and molecular mechanism of TRIP6 in CRC metastasis.Methods: TRIP6 expression was assessed in 226 paired human CRC tumor and adjacent non-tumor tissues, and 15 paired primary and metastatic CRC by RT-qPCR and immunohistochemistry from our cohort, and validated in TCGA cohort (n=286).Function of TRIP6 in metastasis was studied in vitro and in vivo.TRIP6 related pathways were identified by RNA-sequencing, pathway luciferase reporter assays and western blot.Protein interaction of TRIP6 and its downstream effectors was identified by co-immunoprecipitation (co-IP).Colonic epithelial cell tight junction was assessed by transmission electron microscope (TEM).Results: TRIP6 mRNA and protein were significantly up-regulated in CRC tumors compared to adjacent normal tissues in our cohort I (n=150, P<0.0001) and cohort II (n=76, P<0.0001) of CRC primary patients, as well as in TCGA cohort (n=286, P<0.0001).A more pronounced TRIP6 expression was demonstrated in CRC liver metastasis lesions compared to primary CRC tissues (n=15, P<0.0001).TRIP6 disrupted the integrity of tight junction in CRC by directlyinteracting critical tight junction-associated PDZ domain-containing proteins (PARD3, ZO-1, ZO-3 and MAGI1) in colon cancer cell lines by co-IP and immunofluorescence staining.Ectopic expression of TRIP6 in colon cancer cell lines (DLD1 and SW480) significantly promoted cell migration and invasion ability in vitro (all P<0.01) through inducing EMTmetastasis genes.In keeping with the in vitro findings, ectopic expression of TRIP6 in SW480 cells promoted colorectal cancer liver metastasis in nude mice, along with disrupted colonic epithelial cell tight junction by TEM.Moreover, TRIP6 promoted colon cancer cells growth in liver microenvironment.The pro-metastatic effect by TRIP6 was depending on the tight junction-associated PDZ domain-containing protein.On the other hand, knockdown of TRIP6 in HCT116 and SW1116 cells inhibited cell migration ( P<0.01) and invasion (P<0.001)abilities and suppressed liver metastasis in nude mice compared to control group ( P<0.001).Mechanistically, TRIP6 activated AKT/HIF1a signaling as identified by RNA-sequencing and confirmed by increased hypoxia response element (HRE) reporter activity ( P<0.01), enhanced p-Akt and HIF1a and decreased PTEN protein expression.Conclusion: TRIP6 is commonly overexpressed in CRC and more pronounced in liver metastasis.TRIP6 promotes metastasis by directly targeting tight junction-associated proteins to disrupt colonic epithelial cell integrity and byactivating AKT/HIF1a cascade.

Tripartite Motif Protein 6 Promotes Colorectal Cancer Cell Migration and Metastasis via SOCS2-STAT3 Signaling

TRIM14 promotes colorectal cancer cell migration and invasion through the SPHK1/STAT3 pathway

TRIM6 promotes colorectal cancer cells proliferation and response to thiostrepton by TIS21/FoxM1

IL-13/STAT6 Signaling Plays a Critical Role in the Epithelial-Mesenchymal Transition of Colorectal Cancer Cells.

Knockdown of TRIM66 Inhibits Cell Proliferation, Migration and Invasion in Colorectal Cancer Through JAK2/STAT3 Pathway.

TRIM2 is a novel promoter of human colorectal cancer

Tripartite motif protein 6 promotes hepatocellular carcinoma progression via multiple pathways

Rna Interference Against Trim29 Inhibits Migration and Invasion of Colorectal Cancer Cells

Silencing CXCR6 Promotes Epithelial-Mesenchymal Transition and Invasion in Colorectal Cancer by Activating the VEGFA/PI3K/AKT/mTOR Pathway

Sa1172 TRIP6-DEPENDENT ACTIVATION OF AKT/HIF1A CASCADE PROMOTES COLORECTAL CANCER METASTASIS BY DISRUPTING THE INTEGRITY OF CELL TIGHT JUNCTIONS

TRIM59 deficiency promotes M1 macrophage activation and inhibits colorectal cancer through the STAT1 signaling pathway

TRIM16 overexpression inhibits the metastasis of colorectal cancer through mediating Snail degradation

TRIM59 facilitates the proliferation of colorectal cancer and promotes metastasis via the PI3K/AKT pathway

High Expression Level of TRIP6 is Correlated with Poor Prognosis in Colorectal Cancer and Promotes Tumor Cell Proliferation and Migration

Tripartite Motif Containing 62 is a Novel Prognostic Marker and Suppresses Tumor Metastasis Via C-Jun/slug Signaling-Mediated Epithelial-Mesenchymal Transition in Cervical Cancer

Ubiquitin ligase TRIM65 promotes colorectal cancer metastasis by targeting ARHGAP35 for protein degradation

TRIM29 facilitates the epithelial-to-mesenchymal transition and the progression of colorectal cancer via the activation of the Wnt/β-catenin signaling pathway

TRIM21 is Decreased in Colitis-associated Cancer and Negatively Regulates Epithelial Carcinogenesis.

SOX13 promotes colorectal cancer metastasis by transactivating SNAI2 and c-MET

Potential role of TRIM3 as a novel tumour suppressor in colorectal cancer (CRC) development

Tripartite Motif 52 (TRIM52) Promotes Proliferation, Migration, and Regulation of Colon Cancer Cells Associated with the NF-κB Signaling Pathway.